RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34 <sup>+</sup> Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David DiGiusto(Beckman Research Institute), John A. Zaia(City Of Hope National Medical Center), Michael Kalos(Pillar College), Stephen J. Forman(City Of Hope National Medical Center), Sherri Stinson(City of Hope), Simon F. Lacey(University of Pennsylvania), John J. Rossi(City of Hope), Haitang Li(City of Hope), Larry A. Couture(Beckman Research Institute), Joseph Alvarnas(City of Hope), Mingjie Li(Washington University in St. Louis), Lijing Li(City of Hope), Anitha Rao(City of Hope), Shu Mi(Sun Yat-sen University), Priscilla Yam(City Of Hope National Medical Center), Jiing-Kuan Yee(City Of Hope National Medical Center), David S. Hsu(Duke University), Amrita Krishnan(City of Hope), Shirley Xin Li(Shandong University)
Cited by 376
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754